UCLA Neuropsychiatric Institute is a clinical research site located in Los Angeles, California, United States 90024.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
UCLA Neuropsychiatric Institute has participated in 11 clinical trials.
Therapeutic areas: Alzheimer Disease, Dementia, Angelman Syndrome.
Sponsors: University of California, Los Angeles, Hoffmann-La Roche, National Institute of Mental Health (NIMH).
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UCLA Neuropsychiatric Institute has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Neuropsychiatric Institute has 11 clinical trials on record. Their work covers Alzheimer Disease, Dementia, Angelman Syndrome.
Yes — UCLA Neuropsychiatric Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.